$18.53 0.92 (5.22%)
18:08 EDT MYL Stock Quote Delayed 15 Minutes
Previous Close $18.53
Market Cap 9.92B
PE Ratio -
Volume (Avg. Vol.) 5.97M
Day's Range 17.68 - 18.61
52-Week Range 16.63 - 39.59
Dividend & Yield N/A (N/A)
MYL Stock Predictions, Articles, and Mylan News
- From InvestorPlace
- From the Web
Options trading was buzzing in Pfizer, Advanced Micro Devices and Apple on Tuesday. Here are the metrics that matter moving forward.
The stock charts of Southern Co, CF Industries Holdings and National-Oilwell Varco are at inflection points at the midpoint of the week.
The new company emerging from the Pfizer-Mylan deal gets former blockbusters like Lipitor and Celebrex, now generics, and the EpiPen business, which has been an object of scandal.
The stock charts of HBI, TRV and TPR have worked their way into pivotal position as the end of July approaches.
While it was a quiet day for the indices, there were a lot of moves under the surfaces to take note of in the stock market today.
A new Mylan-Pfizer deal that will have the companies taking part in a merger agreement has MYL stock heading higher on Monday.
It looks like there is no end is sight to the EpiPen shortage and Mylan (MYL) stock is taking a beating Wednesday on the news.
Biotech rallied on a $63 billion deal between AbbVie and Allergan. But other than that, it was a tough day for the Nasdaq today.
The stock charts of DISH, FFIV and CRM stock are headed into hump-day on the verge of major moves. Here's what you can expect.
Realty Income, Allergan, Boeing, Mylan and the S&P 500 were big movers on Tuesday. You have to see these must-see stock charts.
The stock charts of CELG, AAL and MYL stock are going to start the new trading week out in a clear technical condition.
Generic drug companies are on discount for investors who want to buy life sciences stocks. Why, and when will this sector recover?
Mylan stock is getting smashed after its fourth-quarter earnings results and full-year outlook. MYL stock could still go lower, though.
As Goldman Sachs moves away from the strong balance sheet investing strategy, here are 6 new stocks to buy.
Abbott is about to report another quarter to cap 2018's strong annual performance. ABT stock also offers a dividend for income investors.
Biotech stocks are likely to continue to be volatile in December, but that may create unique buying opportunities.
Mylan stock jumped ahead following quarterly earnings that impressed investors. Management will continue doing better than expected.
Earnings set to the tone for Toyota, CVS Health, Eli Lilly and Mylan as our top stock trades. But midterms will set the tone for the week.
Mylan stock (MYL) is soaring more than 7% after hours Monday as the. company's third-quarter earnings doubled and beat Wall Street estimates.
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!